Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-10-24
pubmed:abstractText
The present study was undertaken to determine the effects of free ionized calcium influenced by either the anticoagulant used (citrate vs. heparin) or directly varying the calcium levels after treatment of blood with citrate on the antiplatelet efficacy of two classes of GPIIb/IIIa antagonists.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alanine, http://linkedlifedata.com/resource/pubmed/chemical/Amidines, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Citric Acid, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Fab Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Glycoprotein GPIIb-IIIa..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine, http://linkedlifedata.com/resource/pubmed/chemical/abciximab, http://linkedlifedata.com/resource/pubmed/chemical/eptifibatide, http://linkedlifedata.com/resource/pubmed/chemical/orbofiban, http://linkedlifedata.com/resource/pubmed/chemical/roxifiban, http://linkedlifedata.com/resource/pubmed/chemical/tirofiban
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0008-6363
pubmed:author
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
819-26
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10974231-Alanine, pubmed-meshheading:10974231-Amidines, pubmed-meshheading:10974231-Analysis of Variance, pubmed-meshheading:10974231-Antibodies, Monoclonal, pubmed-meshheading:10974231-Anticoagulants, pubmed-meshheading:10974231-Blood Platelets, pubmed-meshheading:10974231-Calcium, pubmed-meshheading:10974231-Citric Acid, pubmed-meshheading:10974231-Fibrinogen, pubmed-meshheading:10974231-Heparin, pubmed-meshheading:10974231-Humans, pubmed-meshheading:10974231-Immunoglobulin Fab Fragments, pubmed-meshheading:10974231-Iodine Radioisotopes, pubmed-meshheading:10974231-Isoxazoles, pubmed-meshheading:10974231-Peptides, pubmed-meshheading:10974231-Platelet Activation, pubmed-meshheading:10974231-Platelet Aggregation, pubmed-meshheading:10974231-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:10974231-Protein Binding, pubmed-meshheading:10974231-Pyrrolidines, pubmed-meshheading:10974231-Tyrosine
pubmed:year
2000
pubmed:articleTitle
Differential antiplatelet efficacy for various GPIIb/IIIa antagonists: role of plasma calcium levels.
pubmed:affiliation
DuPont Pharmaceuticals Co., Wilmington, DE, USA. shaker.a.mousa@dupontpharma.com
pubmed:publicationType
Journal Article, Comparative Study